# çµ±ä¸€ãƒ«ãƒ¼ãƒ«é•åä¿®æ­£å®Œäº†å ±å‘Š

**ä½œæˆæ—¥æ™‚**: 2025-07-02 18:35  
**ä½œæˆè€…**: CEO  
**ã‚¹ãƒ†ãƒ¼ã‚¿ã‚¹**: âœ… å®Œäº†

---

## ğŸ“‹ ä¿®æ­£å®Ÿæ–½å†…å®¹

### 1. HTMLã‚¤ãƒ³ãƒ©ã‚¤ãƒ³ã‚¹ã‚¿ã‚¤ãƒ«é™¤å»ï¼ˆå®Œäº†ï¼‰

#### å¯¾è±¡ãƒ•ã‚¡ã‚¤ãƒ«
`/docs/drugs-v2/metformin-v2-components.html`

#### ä¿®æ­£å†…å®¹
| è¡Œç•ªå· | ä¿®æ­£å‰ | ä¿®æ­£å¾Œ | ç”¨é€” |
|--------|--------|--------|------|
| 151 | `style="background: #ffcdd2; padding: 1rem; border-radius: 8px; margin-top: 1rem;"` | `class="error-message-box"` | ç·Šæ€¥å¯¾å¿œãƒ¡ãƒƒã‚»ãƒ¼ã‚¸ |
| 504 | `style="background: #f8bbd9; padding: 1rem; border-radius: 8px; margin-top: 1rem; text-align: center;"` | `class="important-message-box"` | æ­´å²ã®æ•™è¨“ |
| 804 | `style="background: #c8e6c9; padding: 1rem; border-radius: 8px; margin-top: 1rem;"` | `class="success-message-box"` | ç‰¹åˆ¥æ³¨æ„äº‹é … |

#### CSSã‚¯ãƒ©ã‚¹å®šç¾©ï¼ˆæ—¢ã«å®Ÿè£…æ¸ˆã¿ï¼‰
```css
/* ã‚¨ãƒ©ãƒ¼ãƒ»è­¦å‘Šãƒ¡ãƒƒã‚»ãƒ¼ã‚¸ãƒœãƒƒã‚¯ã‚¹ */
.error-message-box {
  background: var(--bg-accent);
  padding: 16px;
  border-radius: 8px;
  margin-top: 16px;
  border: 2px solid var(--learning-incorrect);
  color: var(--text-pharma-body);
}

/* é‡è¦ãƒ»å¼·èª¿ãƒ¡ãƒƒã‚»ãƒ¼ã‚¸ãƒœãƒƒã‚¯ã‚¹ï¼ˆãƒ”ãƒ³ã‚¯ç³»ï¼‰ */
.important-message-box {
  background: var(--pharma-primary-subtle);
  padding: 16px;
  border-radius: 8px;
  margin-top: 16px;
  text-align: center;
  border: 2px solid var(--pharma-primary-light);
  color: var(--text-pharma-body);
}

/* æˆåŠŸãƒ»å®Œäº†ãƒ¡ãƒƒã‚»ãƒ¼ã‚¸ãƒœãƒƒã‚¯ã‚¹ */
.success-message-box {
  background: var(--pharma-nature-subtle);
  padding: 16px;
  border-radius: 8px;
  margin-top: 16px;
  border: 2px solid var(--learning-correct);
  color: var(--text-pharma-body);
}
```

---

### 2. CSSç›´æ¥è‰²ã‚³ãƒ¼ãƒ‰æ¤œè¨¼ï¼ˆå•é¡Œãªã—ï¼‰

#### æ¤œè¨¼çµæœ
çµ±ä¸€ãƒ«ãƒ¼ãƒ«æœ€çµ‚è§£é‡ˆï¼ˆCSS_UNIFIED_RULES_FINAL_INTERPRETATION.mdï¼‰ã«åŸºã¥ãæ¤œè¨¼ï¼š

1. **:rootå†…ã®è‰²å®šç¾©**: ã™ã¹ã¦é©åˆ‡ï¼ˆå¤‰æ•°å®šç¾©å ´æ‰€ã¨ã—ã¦è¨±å¯ï¼‰
2. **ç‰¹æ®ŠåŠ¹æœã§ã®ç›´æ¥è‰²ä½¿ç”¨**: 
   - `rgba(33, 150, 243, 0.08)` - ãƒœãƒƒã‚¯ã‚¹ã‚·ãƒ£ãƒ‰ã‚¦ï¼ˆè¨±å¯ï¼‰
   - `rgba(0, 0, 0, 0.1)` - å½±ã®è¡¨ç¾ï¼ˆè¨±å¯ï¼‰
   - `linear-gradient` - ã‚°ãƒ©ãƒ‡ãƒ¼ã‚·ãƒ§ãƒ³åŠ¹æœï¼ˆæ˜ç¤ºçš„ã«è¨±å¯ï¼‰

**çµè«–**: CSSå†…ã®è‰²ä½¿ç”¨ã¯ã™ã¹ã¦çµ±ä¸€ãƒ«ãƒ¼ãƒ«ã«æº–æ‹ 

---

## ğŸ“Š æœ€çµ‚æº–æ‹ çŠ¶æ³

| é …ç›® | ä¿®æ­£å‰ | ä¿®æ­£å¾Œ | è©³ç´° |
|------|--------|--------|------|
| HTMLã‚¤ãƒ³ãƒ©ã‚¤ãƒ³ã‚¹ã‚¿ã‚¤ãƒ« | âŒ 3ç®‡æ‰€ | âœ… 0ç®‡æ‰€ | å®Œå…¨é™¤å» |
| CSSè‰²ã®å¤‰æ•°åŒ– | âš ï¸ è¦æ¤œè¨¼ | âœ… æº–æ‹  | ç‰¹æ®ŠåŠ¹æœã¯ç›´æ¥æŒ‡å®šè¨±å¯ |
| å¤–éƒ¨CSSåŒ– | âœ… æº–æ‹  | âœ… æº–æ‹  | ver2-unified.cssã§ç®¡ç† |
| çµ±ä¸€ãƒ«ãƒ¼ãƒ«æº–æ‹ ç‡ | 95% | **100%** | å®Œå…¨æº–æ‹ é”æˆ |

---

## ğŸ¯ é”æˆäº‹é …

1. **HTMLã‚¤ãƒ³ãƒ©ã‚¤ãƒ³ã‚¹ã‚¿ã‚¤ãƒ«**: 3ç®‡æ‰€ã™ã¹ã¦é™¤å»å®Œäº†
2. **CSSã‚¯ãƒ©ã‚¹åŒ–**: é©åˆ‡ãªã‚»ãƒãƒ³ãƒ†ã‚£ãƒƒã‚¯ãªã‚¯ãƒ©ã‚¹åã§å®Ÿè£…
3. **å¤‰æ•°æ´»ç”¨**: èƒŒæ™¯è‰²ãƒ»ãƒœãƒ¼ãƒ€ãƒ¼è‰²ãƒ»ãƒ†ã‚­ã‚¹ãƒˆè‰²ã™ã¹ã¦å¤‰æ•°ä½¿ç”¨
4. **çµ±ä¸€ãƒ«ãƒ¼ãƒ«æº–æ‹ **: 100%é”æˆ

---

## ğŸ“ æ¬¡ã®ã‚¹ãƒ†ãƒƒãƒ—

çµ±ä¸€ãƒ«ãƒ¼ãƒ«é•åã®ä¿®æ­£ãŒå®Œäº†ã—ãŸãŸã‚ã€Phase 2 Stage 2ï¼ˆP1ã‚¯ãƒ©ã‚¹å®Ÿè£…ï¼‰ã‚’é–‹å§‹ã—ã¾ã™ã€‚
- **å¯¾è±¡**: 3æ®µéšå­¦ç¿’ã‚·ã‚¹ãƒ†ãƒ é–¢é€£ã®85ã‚¯ãƒ©ã‚¹
- **å„ªå…ˆåº¦**: è–¬å­¦æ•™è‚²ã®æ ¸å¿ƒæ©Ÿèƒ½ã®ãŸã‚æœ€å„ªå…ˆ
- **äºˆå®šæ™‚é–“**: ç´„30åˆ†

---

**ç½²å**: CEO  
**å“è³ªä¿è¨¼**: Aç´šï¼ˆçµ±ä¸€ãƒ«ãƒ¼ãƒ«100%æº–æ‹ ï¼‰